logo

TECX

TectonicยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

TECX Profile

Tectonic Therapeutic, Inc.

A clinical stage biotechnology company focused on developing G protein coupled receptor (GPCR) targeted therapeutic proteins

Biological Technology
--
06/21/2018
NASDAQ Stock Exchange
51
12-31
Common stock
490 Arsenal Way, Suite 210, Watertown, MA 02472
--
Tectonic Therapeutic, Inc., is a corporation organized under the laws of the State of Delaware. The Company is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that regulate the activity of G protein-coupled receptors (" GPCRs "). Leveraging its proprietary technology platform called GEODe (" GPCR Engineered for Optimal Discovery "), Tectonic focuses on developing biopharmaceuticals to overcome existing challenges of GPCR-targeted drug discovery and harness the human body to change the course of disease. Tectonic focuses on areas with significant unmet medical needs, which are often areas with poor or non-existent treatment options, because new drugs in these areas have the potential to improve the quality of life of patients.